Preparation of magnetic polybutylcyanoacrylate nanospheres encapsulated with aclacinomycin A and its effect on gastric tumor

Table 1 Tumor mass on the 11th day and TIR of the five groups (n = 6, mean ± SD)

Group	Tumor mass (g)	TIR (%)
ACM	1.06 ± 0.27a	22.63
High dosage of MPNS-ACM	0.65 ± 0.26aceg	52.55
Low dosage of MPNS-ACM	0.95 ± 0.15ag	30.66
MPNS	1.23 ± 0.25	10.22
Control	1.37 ± 0.21	//

^aP < 0.05 vs control group;

^cP < 0.05 vs ACM group;

^eP < 0.05 vs group of low dosage MPNS-ACM;

^gP < 0.05 vs MPNS group.